Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor: A critical role for costimulation by B7 on both tumor and host antigen-presenting cells

Cancer Research

Volumn 58, Issue 15, 1998, Pages 3376-3384

  Maric, Maja ^a   Zheng, Pan ^a   Sarma, Supria ^a   Guo, Yong ^a   Liu, Yang ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; MOUSE; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CELL CYCLE; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PLASMACYTOMA; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0032146258     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Barker, C. F., and Billingham, R. F. The role of afferent lymphatics in the rejection of skin homografts. J. Exp. Med., 128: 197-221, 1968.
2. Kundig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. L. J., Battegay, M., Lother, H., Gessner, A., Kuhlcke, K., Ohashi, P. S., Hengartner, H., and Zinkernagel, R. M. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (Washington DC), 268: 1343-1346, 1995.
3. Bradley, L. M., Watson, S. R., and Swain, S. L. Entry of naive CD4 T cells into lymph node requires L-selectin. J. Exp. Med., 180: 2401-2406, 1994.
4. Yang, G., Mizuno, M. T., Hellstrom, K. E., and Chen, L. B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes. J. Immunol., 158: 851-858, 1997.
5. Zinkernagel, R. M. Immunology taught by viruses. Science (Washington DC), 271: 173-178, 1996.
6. Bevan, M. J. Cross-priming of a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med., 143: 1283-1288, 1976.
7. Brestcher, P., and Cohn, M. A theory of self-nonself discrimination. Science (Washington DC), 169: 1042-1049, 1970.
8. Lafferty, K. J., and Cunningham, A. J. A new analysis of alloreactivity. Aust. J. Exp. Biol. Med. Sci., 53: 27-42, 1975.
9. Mueller, D. L., Jenkins, M. K., and Schwartz, R. H. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen occupancy. Annu. Rev. Immunol., 7: 445-480, 1989.
10. Janeway, C. A., Jr. Immunogenicity: signal 1, 2, 3 and 0. Immunol. Today, 10: 283-288, 1989.
11. Liu, Y., and Linsley, P. S. Costimulation of T cell growth. Curr. Opin. Immunol., 4: 265-270, 1992.
12. Janeway, C. A., Jr., and Bottomly, K. Signals and signs for lymphocyte responses. Cell, 76: 275-285, 1994.
13. Linsley, P. S., Clark, E. A., and Ledbetter, J. A. The T cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen B7. Proc. Natl. Acad. Sci. USA, 87: 5031-5035, 1990.
14. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., and Ledbetter, J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J. Exp. Med., 173: 721-730, 1991.
15. Azuma, M., Cayabayab, M., Buck, D., Philips, J. H., and Lanier, L. L. B70 antigen is a second ligand for CTLA4 and CD28. Nature (Lond.), 366: 76-78, 1993.
16. Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P. S., and Hodes, R. J. Identification of an alternative CTLA4 ligand co-stimulatory for T cell activation. Science (Washington DC), 262: 905-907, 1993.
17. Freeman, G. L., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Jr., Lombard, G. S., and Nadler, L. M. Cloning of B7-2: a CTLA4 counter-receptor that costimulates human T cell proliferation. Science (Washington DC), 262: 909-911, 1993.
18. Wu, Y., Guo, Y., and Liu, Y. A major co-stimulatory molecule, CTLA4 ligand A, is distinct from B7. J. Exp. Med., 178: 1789-1793, 1993.
19. Lafferty, K. J., Prowse, S. J., Simeonovich, C. J., and Warren, H. Immunobiology of tissue transplantation: a return to passenger leukocyte concept. Annu. Rev. Immunol., 1: 143-174, 1983.
20. Liu, Y., and Janeway, C. A., Jr. Microbial induction of costimulatory activity for CD4 T cell growth. Int. Immunol., 3: 323-332, 1991.
21. Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., Muramatsu, S., Hodes, R. J., and Steinman, R. M. The tissue-distribution of B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during in vitro maturation. J. Exp. Med., 180: 1849-1860, 1994.
22. Chen, L. P., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of anti-tumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA4. Cell, 71: 1093-1102, 1992.
23. + T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
24. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., and Glimcher, L. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated MHC class II molecules. Proc. Natl. Acad. Sci. USA, 90: 7015-7019, 1993.
25. Ramarathinam, L., Castle, M., Wu, Y., and Liu, Y. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med., 179: 1205-1214, 1994.
26. Wang, Y-C., Zhu, L., McHugh, R., Sell, K. W., and Selvaraj, P. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice. Eur. J. Immunol., 25: 1163-1167, 1995.
27. Takesue, B. Y., Pyle, J. M., and Mokyr, M. B. Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy. Cancer Res., 50: 7641-7649, 1990.
28. Ramarathinam, R., Sarma, S., Maric, M., Zhao, M., Yang, G., Chen, L., and Liu, Y. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol., 155: 5323-5329, 1995.
29. Dumont, F. J., Habbersett, R. C., Coker, L. C., Nichols, E. A., and Treffinger, E. A. High level expression of the plasma cell antigen PC.1 on the T cell subset expanding in MRL/MpJ-lpr/lpr mice: detection with a xenogeneic monoclonal antibody and allo antisera. Cell. Immunol., 96: 327-337, 1985.
30. Razi-Wolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadler, L., and Reiser, H. Expression and function of the murine B7-antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA, 89: 4210-4215, 1992.
31. Freeman, G. J., Freeman, A. S., Segal, J. M., Horowritz, J., Daley, J., and Nadler, L. M. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol., 143: 2714-2722, 1989.
32. Guo, Y., Wu, Y., Zhao, M., Kong, X-P., and Liu, Y. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. J. Exp. Med., 181: 1345-1355, 1995.
33. Lethe, B., Van der Eynde, B., Van Pel, A., Corradin, G., and Boon, T. Mouse tumor rejection antigen P815A and P815B: two epitopes carried by a single peptide. Eur. J. Immunol., 22: 2283-2288, 1992.
34. Goddard, A. D., Yuan, J. Q., Fairbairn, L., Dexter, M., Borrow, J., and Solomon, E. Cloning of the murine homolog of the leukemia-associated PML gene. Mamm. Genome, 7: 732-737, 1995.
35. Maric, M., Chen, L., Sherry, B., and Liu, Y. A mechanism for selective recruitment of CD8 T cells into a B7-1-transfected plasmacytoma: role of macrophage inflammatory protein 1α. J. Immunol., 159: 360-368, 1997.
36. Azuma, M., Cayabab, M., Buck, D., Phillips, J. H., and Lanier, L. L. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol., 152: 3361-3369, 1992.
37. Chambers, B. J., Salcedo, M., and Ljunggren, H-G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity, 5: 311-317, 1996.
38. Gretz, J. E., Kaldjian, E. P., Anderson, A. O., and Shaw, S. Sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic. J. Immunol., 157: 495-499, 1996.
39. Ada, G. L., and Jones, P. D. The immune response to influenza infection. Curr. Top. Microbiol. Immunol., 128: 1-54, 1986.
40. Huang, A. Y. C., Bruce, A. T., Pardoll, D. M., and Levitsky, H. I. Does B7-1 expression confer antigen-presenting capacity to tumors in vivo. J. Exp. Med., 183: 769-776, 1996.
41. Baskar, S., Clements, V. K., Glimcher, L. H., Nabavi, N., and Ostrand-Rosenberg, S. Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules. J. Immunol., 156: 3821-3827, 1996.
42. Azuma, M., Cayabayab, M., Buck, D., Philips, J. H., and Lanier, L. L. CD28 interaction with B7 costimulates allogeneic proliferative responses and cytotoxicity mediated by small, resting lymphocytes. J. Exp. Med., 175: 353-361, 1992.
43. Azuma, M., Cayabayab, M., Philips, J. H., and Lanier, L. L. Requirement of CD28-dependent T-cell mediated cytotoxicity. J. Immunol., 150: 2091-2096, 1993.
44. Wu, T-C., Huang, A. Y. C., Jaffee, E. M., Levitsky, H., and Pardoll, D. M. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med., 182: 1415-1421, 1995.
45. Suto, R., and Srivastava, P. A mechanism for the specific immunogenicity of the heat shock protein-chaperoned peptides. Science (Washington DC), 269: 1585-1588, 1995.
46. Liu, Y., Jones, B., Sullivan, K., Aruffo, A., Linsley, P. S., and Janeway, C. A., Jr. The heat-stable antigen is a co-stimulatory molecule for CD4 T cells. J. Exp. Med., 175: 437-445, 1992.
47. Griggs, N. D., Agersborg, S. A., Noelle, R. J., Ledbetter, J. A., Linsley, P. S., and Tung, K. S. The relative contribution of the CD28 and gp39 costimulatory pathway in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med., 183: 801-810, 1996.
48. Guo, Y., Wu, Y., Shinde, S., and Liu, Y. Identification of CD44H as a costimulatory molecule rapidly induced by CD40 ligand. J. Exp. Med., 184: 955-961, 1996.